The Assembly of Laminin-5 Subunits (*)

  1. Chihiro Matsui(§),
  2. C. Kathy Wang,
  3. Charlotte F. Nelson,
  4. Eugene A. Bauer and
  5. Warren K. Hoeffler(¶)
  1. From the Department of Dermatology, Stanford University School of Medicine, Stanford, California 94305
  1. To whom correspondence should be addressed. Tel.: 415-723-7843; Fax: 415-723-8762.

Abstract

Laminin-5 is a heterotrimer composed of α3, β3, and Graphic2 chains, produced by keratinocytes and the human squamous cell carcinoma line (SCC-25), and is one of the candidate proteins for the genetic lesion in junctional epidermolysis bullosa. Two-dimensional SDS-polyacrylamide gel electrophoresis (first dimension, nonreducing conditions; second dimension, reducing conditions) revealed that the immunoprecipitated laminin-5 from a SCC-25 cell fraction consisted of α3, β3, and Graphic2 monomers, a β3Graphic2 heterodimer, and an α3β3Graphic2 heterotrimer. The presence of the β3Graphic2 heterodimer, but not heterodimers containing an α3 chain and any of the other chains, was suggestive of assembly of laminin-5 proceeding from a β3Graphic2 heterodimer to an α3β3Graphic2 heterotrimer. We showed, by cotransfection experiments using full-length recombinant β3 and Graphic2 chains in a human cell line devoid of endogenous laminin-5, that stable heterodimers can be formed in the absence of α3 chain expression. In the SCC-25 cell fraction, the α3 monomer pool was the smallest of the monomers. Pulse-chase experiments using the cell fraction also indicated that the heterotrimer was assembled after a 10-min pulse and was nearly absent after a 24-h chase. These results are consistent with the synthesis of α3 being limiting for heterotrimer assembly, with rapid association of the α3 chain with β3Graphic2 heterodimers to form complete heterotrimers. Treatment with tunicamycin reduced the size of each of the laminin-5 subunits, indicating that all chains are glycosylated, but that N-linked glycosylation is not necessary for chain assembly and secretion.

Footnotes

  • § Partially supported by a scholarship from the Uehara Memorial Foundation.

  • * This work was supported by NIAMS Grants AR41045-03 and AR19537. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    HJEB

    Herlitz junctional epidermolysis bullosa

    DMEM

    Dulbecco's modified Eagle's medium

    PAGE

    polyacylamide gel electrophoresis

    recombinant β3

    rGraphic

    recombinant Graphic2.

    • Received May 8, 1995.
    • Revision received July 20, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement